APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Impurity Analysis Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical Impurity Analysis Service Industry Growth and Trends Forecast to 2032

1 January 2026111 pages

Choose your research edition.

Industry ResearchPharmaceutical Impurity Analysis Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Impurity Analysis Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Impurity Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Impurity Analysis Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Impurity Analysis Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmaceutical Impurity Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmaceutical Impurity Analysis Service market include Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs and Impact Analytical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical Impurity Analysis Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical Impurity Analysis Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Impurity Analysis Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Impurity Analysis Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Impurity Analysis Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical Impurity Analysis Service Market by Company

Intertek

Creative Proteomics

Emery Pharma

Agilent

Vimta

Alfa Chemistry

Eurofins

Alera Labs

Impact Analytical

Leeder Analytical

Nelson Labs

Reading Scientific Services

Regis Technologies

Selvita

SGS

Pharmaceutical Impurity Analysis Service Segment by Type

Organic Impurity Analysis

Inorganic Impurity Analysis

Residual Solvent Analysis

Others

Pharmaceutical Impurity Analysis Service Segment by Application

Pharmaceutical Industry

Agriculture

Biotechnology

Others

Pharmaceutical Impurity Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Impurity Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Impurity Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Impurity Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmaceutical Impurity Analysis Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Impurity Analysis Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmaceutical Impurity Analysis Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2021-2026) Table 4. Global Pharmaceutical Impurity Analysis Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2027-2032) Table 6. Global Pharmaceutical Impurity Analysis Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2026) Table 9. Global Pharmaceutical Impurity Analysis Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmaceutical Impurity Analysis Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2026) Table 24. Global Pharmaceutical Impurity Analysis Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmaceutical Impurity Analysis Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmaceutical Impurity Analysis Service Industry Trends Table 37. Pharmaceutical Impurity Analysis Service Industry Drivers Table 38. Pharmaceutical Impurity Analysis Service Industry Opportunities and Challenges Table 39. Pharmaceutical Impurity Analysis Service Industry Restraints Table 40. Global Pharmaceutical Impurity Analysis Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Company (2021-2026) Table 42. Global Pharmaceutical Impurity Analysis Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmaceutical Impurity Analysis Service Key Company Headquarters & Area Served Table 44. Global Pharmaceutical Impurity Analysis Service Company, Product Type & Application Table 45. Global Pharmaceutical Impurity Analysis Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmaceutical Impurity Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Intertek Company Information Table 49. Intertek Business Overview Table 50. Intertek Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Intertek Pharmaceutical Impurity Analysis Service Product Portfolio Table 52. Intertek Recent Development Table 53. Creative Proteomics Company Information Table 54. Creative Proteomics Business Overview Table 55. Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio Table 57. Creative Proteomics Recent Development Table 58. Emery Pharma Company Information Table 59. Emery Pharma Business Overview Table 60. Emery Pharma Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio Table 62. Emery Pharma Recent Development Table 63. Agilent Company Information Table 64. Agilent Business Overview Table 65. Agilent Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Agilent Pharmaceutical Impurity Analysis Service Product Portfolio Table 67. Agilent Recent Development Table 68. Vimta Company Information Table 69. Vimta Business Overview Table 70. Vimta Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Vimta Pharmaceutical Impurity Analysis Service Product Portfolio Table 72. Vimta Recent Development Table 73. Alfa Chemistry Company Information Table 74. Alfa Chemistry Business Overview Table 75. Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio Table 77. Alfa Chemistry Recent Development Table 78. Eurofins Company Information Table 79. Eurofins Business Overview Table 80. Eurofins Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio Table 82. Eurofins Recent Development Table 83. Alera Labs Company Information Table 84. Alera Labs Business Overview Table 85. Alera Labs Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio Table 87. Alera Labs Recent Development Table 88. Impact Analytical Company Information Table 89. Impact Analytical Business Overview Table 90. Impact Analytical Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio Table 92. Impact Analytical Recent Development Table 93. Leeder Analytical Company Information Table 94. Leeder Analytical Business Overview Table 95. Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio Table 97. Leeder Analytical Recent Development Table 98. Nelson Labs Company Information Table 99. Nelson Labs Business Overview Table 100. Nelson Labs Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio Table 102. Nelson Labs Recent Development Table 103. Reading Scientific Services Company Information Table 104. Reading Scientific Services Business Overview Table 105. Reading Scientific Services Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio Table 107. Reading Scientific Services Recent Development Table 108. Regis Technologies Company Information Table 109. Regis Technologies Business Overview Table 110. Regis Technologies Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio Table 112. Regis Technologies Recent Development Table 113. Selvita Company Information Table 114. Selvita Business Overview Table 115. Selvita Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Selvita Pharmaceutical Impurity Analysis Service Product Portfolio Table 117. Selvita Recent Development Table 118. SGS Company Information Table 119. SGS Business Overview Table 120. SGS Pharmaceutical Impurity Analysis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. SGS Pharmaceutical Impurity Analysis Service Product Portfolio Table 122. SGS Recent Development Table 123. North America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2026) Table 126. North America Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Pharmaceutical Impurity Analysis Service Market Share Forecast by Country (2027-2032) Table 128. Europe Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2026) Table 131. Europe Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Pharmaceutical Impurity Analysis Service Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2026) Table 136. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Share Forecast by Country (2027-2032) Table 138. Latin America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2026) Table 141. Latin America Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Pharmaceutical Impurity Analysis Service Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2026) Table 146. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmaceutical Impurity Analysis Service Product Image Figure 3. Global Pharmaceutical Impurity Analysis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmaceutical Impurity Analysis Service Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2021-2032) Figure 7. North America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Organic Impurity Analysis Image Figure 13. Global Organic Impurity Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Inorganic Impurity Analysis Image Figure 15. Global Inorganic Impurity Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Residual Solvent Analysis Image Figure 17. Global Residual Solvent Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Pharmaceutical Impurity Analysis Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Pharmaceutical Impurity Analysis Service Market Share by Type 2025 VS 2032 Figure 22. North America Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2032) Figure 23. Europe Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2032) Figure 25. Latin America Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Industry Image Figure 28. Global Pharmaceutical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Agriculture Image Figure 30. Global Agriculture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Biotechnology Image Figure 32. Global Biotechnology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Pharmaceutical Impurity Analysis Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pharmaceutical Impurity Analysis Service Market Share by Application 2025 VS 2032 Figure 37. North America Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2032) Figure 38. Europe Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2032) Figure 40. Latin America Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Pharmaceutical Impurity Analysis Service Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Pharmaceutical Impurity Analysis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Pharmaceutical Impurity Analysis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 47. Europe Pharmaceutical Impurity Analysis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pharmaceutical Impurity Analysis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 50. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 53. Latin America Pharmaceutical Impurity Analysis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Pharmaceutical Impurity Analysis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 56. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Impurity Analysis
  • Inorganic Impurity Analysis
  • Residual Solvent Analysis
  • Others
Applications
  • Pharmaceutical Industry
  • Agriculture
  • Biotechnology
  • Others
Companies covered
  • Intertek
  • Creative Proteomics
  • Emery Pharma
  • Agilent
  • Vimta
  • Alfa Chemistry
  • Eurofins
  • Alera Labs
  • Impact Analytical
  • Leeder Analytical
  • Nelson Labs
  • Reading Scientific Services
  • Regis Technologies
  • Selvita
  • SGS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmaceutical Impurity Analysis Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmaceutical Impurity Analysis Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmaceutical Impurity Analysis Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmaceutical Impurity Analysis Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  8. 1.5.1 North America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Growth Rate (2021-2032)
2 Pharmaceutical Impurity Analysis Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Organic Impurity Analysis
  3. 2.1.2 Inorganic Impurity Analysis
  4. 2.1.3 Residual Solvent Analysis
  5. 2.1.4 Others
  6. 2.2 Global Pharmaceutical Impurity Analysis Service Market Size by Type
  7. 2.2.1 Global Pharmaceutical Impurity Analysis Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Pharmaceutical Impurity Analysis Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Pharmaceutical Impurity Analysis Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Pharmaceutical Impurity Analysis Service Market Size by Regions
  11. 2.3.1 North America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Impurity Analysis Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Industry
  3. 3.1.2 Agriculture
  4. 3.1.3 Biotechnology
  5. 3.1.4 Others
  6. 3.2 Global Pharmaceutical Impurity Analysis Service Market Size by Application
  7. 3.2.1 Global Pharmaceutical Impurity Analysis Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Pharmaceutical Impurity Analysis Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Pharmaceutical Impurity Analysis Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Pharmaceutical Impurity Analysis Service Market Size by Regions
  11. 3.3.1 North America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Pharmaceutical Impurity Analysis Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmaceutical Impurity Analysis Service Industry Trends
  2. 4.2 Pharmaceutical Impurity Analysis Service Industry Drivers
  3. 4.3 Pharmaceutical Impurity Analysis Service Industry Opportunities and Challenges
  4. 4.4 Pharmaceutical Impurity Analysis Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmaceutical Impurity Analysis Service Revenue (2021-2026)
  2. 5.2 Global Pharmaceutical Impurity Analysis Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmaceutical Impurity Analysis Service Key Company Headquarters & Area Served
  4. 5.4 Global Pharmaceutical Impurity Analysis Service Company, Product Type & Application
  5. 5.5 Global Pharmaceutical Impurity Analysis Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmaceutical Impurity Analysis Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmaceutical Impurity Analysis Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmaceutical Impurity Analysis Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Intertek
  2. 6.1.1 Intertek Company Information
  3. 6.1.2 Intertek Business Overview
  4. 6.1.3 Intertek Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Intertek Pharmaceutical Impurity Analysis Service Product Portfolio
  6. 6.1.5 Intertek Recent Developments
  7. 6.2 Creative Proteomics
  8. 6.2.1 Creative Proteomics Company Information
  9. 6.2.2 Creative Proteomics Business Overview
  10. 6.2.3 Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio
  12. 6.2.5 Creative Proteomics Recent Developments
  13. 6.3 Emery Pharma
  14. 6.3.1 Emery Pharma Company Information
  15. 6.3.2 Emery Pharma Business Overview
  16. 6.3.3 Emery Pharma Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio
  18. 6.3.5 Emery Pharma Recent Developments
  19. 6.4 Agilent
  20. 6.4.1 Agilent Company Information
  21. 6.4.2 Agilent Business Overview
  22. 6.4.3 Agilent Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Agilent Pharmaceutical Impurity Analysis Service Product Portfolio
  24. 6.4.5 Agilent Recent Developments
  25. 6.5 Vimta
  26. 6.5.1 Vimta Company Information
  27. 6.5.2 Vimta Business Overview
  28. 6.5.3 Vimta Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Vimta Pharmaceutical Impurity Analysis Service Product Portfolio
  30. 6.5.5 Vimta Recent Developments
  31. 6.6 Alfa Chemistry
  32. 6.6.1 Alfa Chemistry Company Information
  33. 6.6.2 Alfa Chemistry Business Overview
  34. 6.6.3 Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio
  36. 6.6.5 Alfa Chemistry Recent Developments
  37. 6.7 Eurofins
  38. 6.7.1 Eurofins Company Information
  39. 6.7.2 Eurofins Business Overview
  40. 6.7.3 Eurofins Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio
  42. 6.7.5 Eurofins Recent Developments
  43. 6.8 Alera Labs
  44. 6.8.1 Alera Labs Company Information
  45. 6.8.2 Alera Labs Business Overview
  46. 6.8.3 Alera Labs Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio
  48. 6.8.5 Alera Labs Recent Developments
  49. 6.9 Impact Analytical
  50. 6.9.1 Impact Analytical Company Information
  51. 6.9.2 Impact Analytical Business Overview
  52. 6.9.3 Impact Analytical Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
  54. 6.9.5 Impact Analytical Recent Developments
  55. 6.10 Leeder Analytical
  56. 6.10.1 Leeder Analytical Company Information
  57. 6.10.2 Leeder Analytical Business Overview
  58. 6.10.3 Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
  60. 6.10.5 Leeder Analytical Recent Developments
  61. 6.11 Nelson Labs
  62. 6.11.1 Nelson Labs Company Information
  63. 6.11.2 Nelson Labs Business Overview
  64. 6.11.3 Nelson Labs Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio
  66. 6.11.5 Nelson Labs Recent Developments
  67. 6.12 Reading Scientific Services
  68. 6.12.1 Reading Scientific Services Company Information
  69. 6.12.2 Reading Scientific Services Business Overview
  70. 6.12.3 Reading Scientific Services Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio
  72. 6.12.5 Reading Scientific Services Recent Developments
  73. 6.13 Regis Technologies
  74. 6.13.1 Regis Technologies Company Information
  75. 6.13.2 Regis Technologies Business Overview
  76. 6.13.3 Regis Technologies Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio
  78. 6.13.5 Regis Technologies Recent Developments
  79. 6.14 Selvita
  80. 6.14.1 Selvita Company Information
  81. 6.14.2 Selvita Business Overview
  82. 6.14.3 Selvita Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Selvita Pharmaceutical Impurity Analysis Service Product Portfolio
  84. 6.14.5 Selvita Recent Developments
  85. 6.15 SGS
  86. 6.15.1 SGS Company Information
  87. 6.15.2 SGS Business Overview
  88. 6.15.3 SGS Pharmaceutical Impurity Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 SGS Pharmaceutical Impurity Analysis Service Product Portfolio
  90. 6.15.5 SGS Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  3. 7.3 North America Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  3. 10.3 South America Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst